Likhitsup, Alisa
Parikh, Neehar D. http://orcid.org/0000-0002-5874-9933
Article History
First Online: 1 October 2019
Compliance with Ethical Standards
:
: No funding was received in relation to this review.
: Alisa Likhitsup declared no conflict of interest. Neehar Parikh has the following declarations: consultant—Eli Lilly, Exelixis, Bristol-Myers Squibb, Freenome; advisory boards—Eisai, Exelixis, Wako, Bayer; research funding—Bayer, Exact Sciences, Target Pharmasolutions.